Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
44 drug samples including Cipla Remdesivir fail to qualify CDSCO test, 1 declared misbranded Medical Dialogues Team14 Aug 2021 3:11 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 44...
Bharat Biotech study on Covaxin, nasal COVID jab cocktail gets DCGI nod: Report Medical Dialogues Team13 Aug 2021 3:49 PM ISTHyderabad: In a significant advancement in Covid 19 vaccine development, Bharat Biotech has got approval from the Drug Controller General of India...
NPPA finds new Chairman in IAS Kamlesh Kumar Pant Ruchika Sharma12 Aug 2021 11:22 AM ISTNew Delhi: Senior bureaucrat Kamlesh Kumar Pant has been appointed as chairperson of the National Pharmaceutical Pricing Authority (NPPA) as part of...
CDSCO asks stakeholders to submit data on rationality, safety, & efficacy of older FDCs Medical Dialogues Team11 Aug 2021 12:55 PM ISTNew Delhi: In order to assess the status of fixed dose combination drugs licensed prior to 1988, the Directorate General of Health Services, Central...
Pfizer Tafamidis to be sold on prescription of cardiologist only: CDSCO panel Medical Dialogues Team10 Aug 2021 5:24 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Setback to Emcure: NPPA refers back price fixation issue of Darunavir, Ritonavir FDC to DoP Medical Dialogues Team9 Aug 2021 2:14 PM ISTNew Delhi: Holding that data is not available, the National Pharmaceuticals Pricing Authority (NPPA) has referred the matter of fixing the retail...
DCGI classifies over 100 medical devices linked to Radiology, Plastic Surgery, Details Medical Dialogues Team8 Aug 2021 11:30 AM ISTNew Delhi: In accordance with the intended use, risk associated with the device, and other parameters specified in the First Schedule of the...
NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 4:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order...
Setback: Mylan proposal for Hydroxychloroquine Sulfate Tablet rejected by CDSCO panel Medical Dialogues Team6 Aug 2021 1:02 PM ISTNew Delhi: In a major setback to Mylan Laboratories, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Sun Pharma Progesterone injection secures CDSCO panel okay Medical Dialogues Team5 Aug 2021 5:52 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Revise clinical trial protocol for Remdesivir powder for inhalation: CDSCO panel tells Lupin Medical Dialogues Team4 Aug 2021 4:00 PM ISTNew Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation,...
